Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda ...

Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...

The healthcare industry came together Wednesday to share thoughts on and reactions to the death of UnitedHealthcare CEO Brian ...

Guindo brings over 25 years of pharmaceutical industry experience and has held various senior executive roles at Merck, including in global strategy and commercial operations. John Evans ...

Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $103.55 which represents a slight increase of $2.18 or 2.15% from the prior close of $101.37. The stock opened at $101.49 and touched ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.

Speaking on the achievement, the CEO of Merck Foundation, Dr. Rasha Kelej, said” I am very proud to share together with our ...

Cambridge-based Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification ...